186 related articles for article (PubMed ID: 11124970)
1. Crystallographic evidence for substrate-assisted catalysis in a bacterial beta-hexosaminidase.
Mark BL; Vocadlo DJ; Knapp S; Triggs-Raine BL; Withers SG; James MN
J Biol Chem; 2001 Mar; 276(13):10330-7. PubMed ID: 11124970
[TBL] [Abstract][Full Text] [Related]
2. Aspartate 313 in the Streptomyces plicatus hexosaminidase plays a critical role in substrate-assisted catalysis by orienting the 2-acetamido group and stabilizing the transition state.
Williams SJ; Mark BL; Vocadlo DJ; James MN; Withers SG
J Biol Chem; 2002 Oct; 277(42):40055-65. PubMed ID: 12171933
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.
Lemieux MJ; Mark BL; Cherney MM; Withers SG; Mahuran DJ; James MN
J Mol Biol; 2006 Jun; 359(4):913-29. PubMed ID: 16698036
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the nature of the Streptomyces plicatus beta-hexosaminidase-bound intermediate using ab initio molecular dynamics simulations.
Greig IR; Zahariev F; Withers SG
J Am Chem Soc; 2008 Dec; 130(51):17620-8. PubMed ID: 19053474
[TBL] [Abstract][Full Text] [Related]
5. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
[TBL] [Abstract][Full Text] [Related]
6. The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease.
Maier T; Strater N; Schuette CG; Klingenstein R; Sandhoff K; Saenger W
J Mol Biol; 2003 May; 328(3):669-81. PubMed ID: 12706724
[TBL] [Abstract][Full Text] [Related]
7. Active-pocket size differentiating insectile from bacterial chitinolytic β-N-acetyl-D-hexosaminidases.
Liu T; Zhang H; Liu F; Chen L; Shen X; Yang Q
Biochem J; 2011 Sep; 438(3):467-74. PubMed ID: 21692744
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of Streptomyces plicatus beta-N-acetylhexosaminidase by comparative molecular modeling and site-directed mutagenesis.
Mark BL; Wasney GA; Salo TJ; Khan AR; Cao Z; Robbins PW; James MN; Triggs-Raine BL
J Biol Chem; 1998 Jul; 273(31):19618-24. PubMed ID: 9677388
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic evidence for substrate-assisted catalysis of β-N-acetylhexosaminidas from Akkermansia muciniphila.
Chen X; Wang J; Liu M; Yang W; Wang Y; Tang R; Zhang M
Biochem Biophys Res Commun; 2019 Apr; 511(4):833-839. PubMed ID: 30846208
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of GlcNAc-processing glycosidases by C-6-azido-NAG-thiazoline and its derivatives.
Krejzová J; Simon P; Kalachova L; Kulik N; Bojarová P; Marhol P; Pelantová H; Cvačka J; Ettrich R; Slámová K; Křen V
Molecules; 2014 Mar; 19(3):3471-88. PubMed ID: 24658571
[TBL] [Abstract][Full Text] [Related]
11. Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease.
Tews I; Perrakis A; Oppenheim A; Dauter Z; Wilson KS; Vorgias CE
Nat Struct Biol; 1996 Jul; 3(7):638-48. PubMed ID: 8673609
[TBL] [Abstract][Full Text] [Related]
12. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
Tse R; Vavougios G; Hou Y; Mahuran DJ
Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characteristics and crystallographic evidence for substrate-assisted catalysis of a β-N-acetylhexosaminidase in Akkermansia muciniphila.
Chen X; Li M; Wang Y; Tang R; Zhang M
Biochem Biophys Res Commun; 2019 Sep; 517(1):29-35. PubMed ID: 31345574
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors.
Kong H; Chen W; Liu T; Lu H; Yang Q; Dong Y; Liang X; Jin S; Zhang J
Carbohydr Res; 2016 Jun; 429():54-61. PubMed ID: 27233493
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
17. GlcNAc-Thiazoline conformations.
Knapp S; Fash D; Abdo M; Emge TJ; Rablen PR
Bioorg Med Chem; 2009 Mar; 17(5):1831-6. PubMed ID: 19223181
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microbial β-N-acetylhexosaminidases by 4-deoxy- and galacto-analogues of NAG-thiazoline.
Krejzová J; Kalachova L; Šimon P; Pelantová H; Slámová K; Křen V
Bioorg Med Chem Lett; 2014 Nov; 24(22):5321-3. PubMed ID: 25442323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
